Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 3/20 | 0.51 |
| ▸ | MMP12 | P39900 | 2/20 | 0.46 |
| ▸ | LSS | P48449 | 1/20 | 0.43 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.40 |
| ▸ | CES1 | P23141 | 2/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2813151 | 0.85 | FFAR1 (0.53) | FFAR1MMP12LSSNAAAALDH1A1 | |
| SCHEMBL5808516 | 0.82 | FFAR1 (0.58) | FFAR1MMP12NAAAALDH1A1FFAR4 | |
| SCHEMBL14596301 | 0.80 | ICMT (0.46) | FFAR1MMP12LSSNAAAALDH1A1 | |
| SCHEMBL29408009 | 0.74 | ALDH1A1 (0.55) | FFAR1ALDH1A1TRPV1HDAC2HDAC1 | |
| SCHEMBL29572084 | 0.73 | ALDH1A1 (0.53) | FFAR1LSSALDH1A1TRPV1HDAC2 | |
| SCHEMBL21486330 | 0.73 | ALDH1A1 (0.53) | FFAR1LSSALDH1A1TRPV1HDAC2 | |
| SCHEMBL8260837 | 0.73 | ALDH1A1 (0.77) | FFAR1MMP12NAAAALDH1A1FFAR4 | |
| SCHEMBL29105881 | 0.73 | ALDH1A1 (0.53) | FFAR1LSSALDH1A1TRPV1HDAC2 | |
| SCHEMBL29098167 | 0.72 | FFAR1 (0.58) | FFAR1MMP12NAAAALDH1A1FFAR4 | |
| SCHEMBL9637227 | 0.72 | FFAR1 (0.48) | FFAR1MMP12LSSKCNH2TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1613585-A4 | COMPOUNDS AND METHODS FOR USE IN TREATING NEOPLASIA AND CANCER BASED UPON INHIBITORS OF ISOPRENYLCYSTEINE METHYLTRANSFERASE | PURDUE RESEARCH FOUNDATION (US) | 2008-07-23 | — | — | EP | disclosed |
| EP-1613585-A2 | COMPOUNDS AND METHODS FOR USE IN TREATING NEOPLASIA AND CANCER BASED UPON INHIBITORS OF ISOPRENYLCYSTEINE METHYLTRANSFERASE | PURDUE RESEARCH FOUNDATION (US) | 2006-01-11 | — | — | EP | disclosed |
| WO-2004087064-A2 | COMPOUNDS AND METHODS FOR USE IN TREATING NEOPLASIA AND CANCER BASED UPON INHIBITORS OF ISOPRENYLCYSTEINE METHYLTRANSFERASE | PURDUE RESEARCH FOUNDATION (US) | 2004-10-14 | — | — | WO | disclosed |